My son Christopher was prescribed Risperdal in 1998. About two months later, he started having heart rhythm problems. I carried him to a cardiologists who said I had nothing to worry about. Then, again in Sept. 1999 he started sweating and having heavy breathing, his heart was racing, so I called an ambulance, which transported him to Grady Memorial in Atlanta. He was given an x-ray, EKG, and blood tests there and I was told he had a hole in his heart and arrythemia. Devistated I carried him to another cardilogists who told me Chris had murmur and I that it was nothing to worry about. I was unsatisfied, so I carried him to another cardiologist in Atlanta, and he said Chris had a leaking valve.

Chris never had heart problems before taking Risperdal. His heart rythm is still abnormal. His cholesterol is high. He is now on 1mg. Riseperdal because he's being weaned off of this medication.

All of the Risperdal Mass Tort and Class Action Attorneys are focusing on diabetes, but Risperdal causes heart problems also. I am looking all over America for Mass Tort Risperdal Attorney who will look into the heart risks of this drug. Please see attached e-mail from FDA.

Dear Patricia,

Thank you for writing the Division of Drug Information, in the FDA's
Center for Drug Evaluation and Research.

Since Risperdal is not a FDA approved indication for ADHD, it is not
included in this list. The cardiovascular risks for Risperdal is
already known, and has already been published in 2003:
http:www.fda.govmedwatchSAFETY2003risperdal.htm

The FDA added a black box warning to the drug labeling already:
http:www.fda.govcderfoilabel2006021444s008s015,020588s024s028s029
,020272s036s041lbl.pdf
This was done to make prescribers aware of this risk, and to prevent it
from occuring.

Best regards,
Drug Information CC
Division of Drug Information
Center for Drug Evaluation and Research
Food and Drug Administration

This communication is consistent with 21CFR10.85(k) and constitutes and
informal communication that represents our best judgment at this time
but does not constitute and advisory opinion, does not necessarily
represent the formal position of the FDA, and does not bind or otherwise
obligate or commit the agency to the views expressed.

-----Original Message-----
From: druginfo@fda.hhs.gov mailto:druginfo@fda.hhs.gov
Sent: Friday, March 09, 2007 12:25 AM
To: CDER DRUG INFO
Subject: DrugInfo Comment Form FDACDER Site



Name: Patricia Wattey

E-Mail: wattleyp@bellsouth.net

Comments: I read the news release regarding the new labels
concerning ADHD approved drugs and the risk of cardiavascular problems
and I was surprised that Risperdal was not on that list. Although,
Risperdal is has not been approved for treating ADHD, it has long been
prescribed by doctors for this condition and for autism before it was
officially approved by the FDA last year. My question is: When will
the FDA finally tell the truth about the renown cardiavascular affects
of Risperdal? Are there any studies currently being done about it's
cardiavascular effects?

URL:





--
No virus found in this incoming message.
Checked by AVG Free Edition.
Version: 7.5.446 Virus Database: 268.18.8714 - Release Date: 382007 10:58 AM

.